High-risk human papillomavirus testing in first-void urine as a novel and non-invasive cervical cancer screening modality—a Danish diagnostic test accuracy study

Abstract Background First-void urine (FVU) collection for high-risk human papillomavirus (hrHPV) testing has game-changing potential to improve cervical cancer prevention among under-screened women who remain unreached by clinician-based cervical cancer screening and vaginal self-sampling. Yet, the...

Полное описание

Библиографические подробности

Главные авторы:	Mette Tranberg, Severien Van Keer, Jørgen Skov Jensen, Pia Nørgaard, Line Winther Gustafson, Anne Hammer, Pinar Bor, Karen Omann Binderup, Christina Blach, Alex Vorsters
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-06-01
Серии:	BMC Medicine
Предметы:	Cervical cancer screening Mass screening HrHPV DNA testing Urinary hrHPV testing Uterine cervical dysplasia Sensitivity and specificity
Online-ссылка:	https://doi.org/10.1186/s12916-025-04149-0
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!